Gør som tusindvis af andre bogelskere
Tilmeld dig nyhedsbrevet og få gode tilbud og inspiration til din næste læsning.
Ved tilmelding accepterer du vores persondatapolitik.Du kan altid afmelde dig igen.
"Topics in Anti-Cancer Research covers new developments in the field of cancer. Novel drugs as anticancer agents include natural and synthetic phenazirines and other anti-cancer compounds. It also encompasses the role of estrogen as estrogen disruptor and strategies targeting cancer stem cells for the treatment of different types of cancer, including myeloma and renal cell cancer. The diversity of researches and topics published in this eBook Series will be valuable to our cancer researchers, clinicians, cancer professionals aiming to develop novel anti-cancer targets and patents for the treatment of various cancers. The topics covered in the Eighth Volume of this series are as follows: - Novel Drugs for Multiple Myeloma - Synthetic Estrogens are Endocrine Disruptors via Inhibition of AF1 Domain of ERs - Recent Progress of Phenazines as Anticancer Agents - Cancer Stem Cell Targeting for Anticancer Therapy: Strategies and Challenges"
Topics in Anti-Cancer Research covers important advances on both experimental (preclinical) and clinical cancer research in drug development. The book series offers readers an insight into current and future therapeutic approaches for the prevention of different types of cancers, synthesizing new anti-cancer agents, new patented compounds, targets and agents for cancer therapy as well as recent molecular and gene therapy research. The comprehensive range of themes covered in each volume will be beneficial to clinicians, immunologists, and R&D experts looking for new anti-cancer targets and patents for the treatment of neoplasms, as well as varied approaches for cancer therapy.The topics covered in the seventh volume of this series include: - The role of inflammation in chemotherapy-induced neuromuscular effects- Advances in nutrigenomics and relevant anti-cancer patents- Stimuli-responsive nanocarriers for on-demand anti-cancer drug release- Harnessing biochemical mechanisms that control autophagy for treating esophageal cance
Tilmeld dig nyhedsbrevet og få gode tilbud og inspiration til din næste læsning.
Ved tilmelding accepterer du vores persondatapolitik.